(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RANDOX DISCOVERY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RANDOX DISCOVERY

ST13

US500000088318383

Class

1, 5, 9, 10

Filing

88318383

Registration

6203127

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

11/24/2020

Trademark type

Word

Nice classes

1, 5, 9, 10

Filing date

02/27/2019

Registration date

11/24/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/24/2020

Last transaction

11/24/2020

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Crumlin, Antrim, GB

Examiner

CIURPITA, DREW

Law office

M50

Current location

PETITIONS OFFICE

Holders and representatives

Holders

Randox Laboratories Ltd
Randox Laboratories Ltd

Representatives

Daniel Frohling LOEB & LOEB LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations for scientific purposes; chemical reagents for scientific or medical research and for use in the analysis of food products; enzymes for use in scientific and medical research applications; protein arrays for use in scientific and medical research applications; diagnostic preparations for analysis of food products and water for scientific or research use; clinical diagnostic preparations for clinical or medical laboratory use; clinical diagnostic reagents for in vitro use for clinical or medical laboratory use; chemical reagents other than for medical or veterinary purposeschemical reagents for detection and monitoring of disease states in vitro for laboratory research purposes; diagnostic proteinsprotein arrays for scientific and medical research featuring antibodies and antigens used for monitoring of disease states in vitro

Class 5

Diagnostic preparations and substances for medical and veterinary purposes; diagnostic kits in the nature of clinical chemistry and immunology test kits for medical use in the detection and monitoring of disease states in vitrochemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiacDOAstrokemetaboliccancerdiabetesfertilitythyroid and DNA arrays; clinical diagnostic preparationsfor medical or veterinary use; clinical diagnostic reagents for in vivo use for medical or veterinary purposes; diagnostic scanning agents for in vivo use for medical or veterinary purposes; diagnostic testing materials for medical use in the detection and monitoring of disease states in vitrochemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiacDOAstrokemetaboliccancerdiabetesfertilitythyroid and DNA arrays; medical diagnostic proteinsprotein arrays for medical diagnostic purposes featuring antibodies and antigens used for medical detection of disease states in vitro; chemical reagentschemical reagents for detection and monitoring of disease states in vitro

Class 9

Downloadable computer software for use in conjunction with in vitro diagnostic testing apparatussoftware for controlling medical and clinical sample processingsample result reporting and test apparatus system robotics; computer hardware for or relating to the analysismonitoringresearch and/or reporting of clinical data; downloadable computer programs for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systemscomputer hardware and downloadable software for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systems for use in conjunction with in vitro diagnostic testing apparatusdownloadable computer software and hardware for controlling medical and clinical sample processing; downloadable computer databases and computer databases recorded on computer media for use in connection with in vitro diagnostic testing apparatusdownloadable electronic data files featuring medical diagnostic sample results; scientific and optical apparatus and instrumentsa benchtop analytical system composed of barcode scanner and associated software for reading barcodesa chemiluminescent detection system in the nature of instruments for measuring chemiluminescencea temperature controlled incubator for laboratory usean electronic reagent and patient sample dispensersuitable for protein and DNA arrays for or relating to the analysismonitoringresearch and/or reporting of clinical datafor use in vitro diagnostic testing procedures for clinicalveterinaryfood and toxicological analysis; clinical analyzers not for medical and veterinary useacidity analyzersliquid analyzersresidual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs for laboratory use; light detectors for use in vitro diagnostic testing proceduresa chemiluminescence detection system not for medical purposes; parts and fittings for all the aforesaid goodsreplacement parts and fittings

Class 10

Medical apparatus and instruments for medical usefor use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulins and hormones; diagnostic apparatus and instruments for medical usefor use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs; diagnostic imaging apparatus for medical useelectromechanical diagnostic analyser utilizing a chemiluminescent detection system for use in in vitro diagnostic testing procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs; medical diagnostic testing apparatus and instruments for use in immunoassay proceduresfor use in the measurement of antibodiesimmunoglobulinshormones and drugs representing various drug classes; light detectors for use in vitro diagnostic testing proceduresa chemiluminescence detection system for medical purposes; clinical analyzers for medical and veterinary useacidity analyzersliquid analyzersresidual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs

Publications

History of USPTO decisions and trademark events.

29 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

11/24/2020

ERTI

TEAS RESPONSE TO PETITION INQUIRY LETTER

10/22/2020

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

10/21/2020

APET

ASSIGNED TO PETITION STAFF

10/20/2020

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

10/14/2020

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

10/13/2020

ABN6

ABANDONMENT - NO USE STATEMENT FILED

10/12/2020

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

09/01/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/10/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/14/2020

PUBO

PUBLISHED FOR OPPOSITION

01/14/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/25/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/06/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

12/05/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/05/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

12/05/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/05/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/22/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/22/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/15/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/15/2019

GNRT

NON-FINAL ACTION E-MAILED

05/15/2019

CNRT

NON-FINAL ACTION WRITTEN

05/15/2019

DOCK

ASSIGNED TO EXAMINER

05/08/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/19/2019

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

03/11/2019

ALIE

ASSIGNED TO LIE

03/11/2019

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

03/06/2019

NWAP

NEW APPLICATION ENTERED

03/02/2019

Continuous trademark protection

Get notified about every new filing that threatens RANDOX DISCOVERY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.